Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins

Infection and Immunity

Volumn 64, Issue 10, 1996, Pages 4047-4053

  Gu, Xin Xing ^a,e   Tsai, Chao Ming ^b   Ueyama, Tomoyo ^a   Barenkamp, Stephen J ^c   Robbins, John B ^d   Lim, David J ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN G;

ANTIGENICITY; ARTICLE; BACTERICIDAL ACTIVITY; DETOXIFICATION; HAEMOPHILUS INFLUENZAE; IMMUNOGENICITY; NONHUMAN; OTITIS MEDIA; PNEUMONIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS;

EID: 0029793893     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.10.4047-4053.1996     Document Type: Article

References (55)

1. Barenkamp, S. J. 1996. Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae modifies experimental otitis media in chinchillas. Infect. Immun. 64:1245-1251.
2. 1a.Barenkamp, S. J., and F. F. Bodor. 1990. Development of serum bactericidal activity following nontypeable Haemophilus influenzae acute otitis media. Pediatr. Infect. Dis. J. 9:333-339.
3. Barenkamp, S. J., and E. Leininger. 1992. Cloning, expression and DNA sequence analysis of the genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis. Infect. Immun. 60:1302-1313.
4. Berman, S. 1995. Current concepts: otitis media in children. N. Engl. J. Med. 332:1560-1565.
5. Bluestone, C. D., and J. O. Klein. 1983. Otitis media with effusion, atelectasis, and eustachian tube dysfunction, p. 356. In C. D. Bluestone and S. E. Stool (ed.), Pediatric otolaryngology. The W. B. Saunders Co., Philadelphia.
6. Brinton, C. C., Jr., M. J. Carter, D. B. Derber, S. Kar, J. A. Kramarik, A. C. C. To, S. C. M. To, and S. W. Wood. 1989. Design and development of pilus vaccines for Haemophilus influenzae diseases. Pediatr. Infect. Dis. J. 8:S54-S61.
7. Campagnari, A. A., M. R. Gupta, K. C. Dudas, T. F. Murphy, M. A. Apicella. 1987. Antigenic diversity of lipooligosaccharides of nontypeable Haemophilus influenzae. Infect. Immun. 55:882-887.
8. Code of Federal Regulations. 1995. Code of Federal Regulations, 21st ed., no. 610.11, p. 50-51. U.S. Government Printing Office, Washington, D.C.
9. Cohen, D., S. Ashkenazi, M. Green, M. Gdalevich, M. Yavzori, R. Slepon, G. Robin, N. Orr, R. Ambar, C. Block, M. Wiener, D. Taylor, L. Hale, J. Sadoff, R. Schneerson, and J. Robbins. Safety and immunogenicity of Shigella flexneri 2a and Shigella sonnet conjugate vaccines: preliminary efficacy of the S. sonnet conjugate in Israeli soldiers. Submitted for publication.
10. Deich, R. A., A. Anilionis, J. Fulginiti, B. J. Metcalf, S. Quataert, T. Quinn-Dey, G. W. Zlotnick, and B. A. Green. 1990. Antigenic conservation of the 15,000-dalton outer membrane lipoprotein PCP of Haemophilus influenzae and biologic activity of anti-PCP antisera. Infect. Immun. 58:3388-3393.
11. DeMaria, T. F., T. Yamaguchi, and D. J. Lira. 1988. Quantitative cytological and histological changes in the middle ear after the injection of nontypeable Haemophilus influenzae endotoxin, p. 320-323. In D. J. Lim, C. D. Bluestone, J. O. Klein, and J. D. Nelson (ed.), Recent advances in otitis media. Marcel Decker, Inc., Philadelphia.
12. Dubois, M., H. Gillis, J. K. Hamilton, A. A. Rebers, and R. Smith. 1956. Colorimetric method for the determination of sugars and related substances. Anal. Biochem. 28:250-256.
13. Faden, H., J. Bernstein, L. Brodsky, J. Stanievich, D. Krystofik, C. Shuff, J. J. Hong, and P. L. Ogra. 1989. Otitis media in children. I. The systemic immune response to nontypeable Haemophilus influenzae. J. Infect. Dis. 160:999-1004.
14. Galanos, C., M. A. Freudenberg, and W. Reutter. 1979. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 76:5939-5943.
15. Gibson, B. W., W. Melaugh, N. J. Phillips, M. A. Apicella, A. A. Campagnari, and J. M. Griffiss. 1993. Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry. J. Bacteriol. 175:2702-2712.
16. Giebink, G. S. 1991. Immunoprophylaxis of otitis media. Adv. Exp. Med. Biol. 303:149-158.
17. Green, B. A., J. E. Parley, T. Quinn-Dey, R. A. Deich, and G. W. Zlotnick. 1991. The e (P4) outer membrane protein of Haemophilus influenzae: biologic activity of anti-c serum and cloning and sequencing of the structural gene. Infect. Immun. 59:3191-3198.
18. Green, B. A., E. S. Meredith, L. Edwards, and K. F. Jones. 1994. Nontypeable Haemophilus influenzae lipooligosaccharide conjugates as vaccine candidates against NTHi, p. 125-129. In Vaccines 94. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
19. Green, B. A., M. E. Vazquez, G. W. Zlotnick, G. Quigley-Reape, J. D. Swarts, I. Green, J. L. Cowell, C. D. Bluestone, and W. J. Doyle. 1993. Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model. Infect. Immun. 61:1950-1957.
20. Gu, X. X., and C. M. Tsai. 1991. Purification of rough-type lipopolysaccharides of Neisseria meningitidis from cells and outer membrane vesicles in spent media. Anal. Biochem. 196:311-318.
21. Gu, X. X., and C. M. Tsai. 1993. Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugates. Infect. Immun. 61:1873-1880.
22. Gu, X. X., C. M. Tsai, M. A. Apicella, and D. J. Lim. 1995. Quantitation and biological properties of released and cell-bound lipooligosaccharide from nontypeable Haemophilus influenzae. Infect. Immun. 63:4115-4120.
23. Gu, X. X., T. Ueyama, A. B. Karpas, C. M. Tsai, and D. J. Lim. 1995. Characterization of monoclonal antibodies to nontypeable Haemophilus influenzae LOS, p. 277. In Abstracts of the Sixth International Symposium on Recent Advances in Otitis Media. The University of Pittsburgh Medical Center, Pittsburgh.
24. Gupta, R. K., S. C. Szu, R. A. Finkelstein, and J. B. Robbins. 1992. Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin. Infect. Immun. 60:3201-3208.
25. +. Description of a novel deep-rough chemotype. Eur. J. Biochem. 177:483-492.
26. Hochstein, H. D., R. J. Elin, J. F. Cooper, E. B. Seligmann, and S. M. Wolff. 1973. Further developments of limulus amebocyte lysate test. Bull. Parenter. Drug Assoc. 27:139-148.
27. Howie, V. M. 1993. Otitis media. Pediatr. Rev. 14:320-323.
28. Kemp, A. H., and M. R. A. Morgan. 1986. Studies on the detrimental effects of bivalent binding in a microtiter plate ELISA and possible remedies. J. Immunol. Methods 94:65-72.
29. Klein, J. O., D. W. Teele, and S. L. Pelton. 1992. New concepts in otitis media: results of investigations of the greater Boston otitis media study group. Adv. Pediatr. 39:127-156.
30. Konadu, E., J. B. Robbins, J. Shiloach, D. A. Bryla, and S. C. Szu. 1994. Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines. Infect. Immun. 62:5048-5054.
31. Kyd, J. M., M. L. Dunkley, and A. W. Cripps. 1995. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immu- nization with P6 in a rat model. Infect. Immun. 63:2931-2940.
32. Makela, P. H., P. Karma, M. Sipila, J. Pukander, and M. Leinonen. 1983. Possibilities of preventing otilis media by vaccination. Scand. J. Infect. Dis. Suppl. 39:34-38.
33. Mandrell, R. E., R. McLaughlin, Y. A. Kwaik, A. Lesse, R. Yamasaki, G. Bradford, S. M. Spinola, and M. A. Apicella. 1992. Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated. Infect. Immun. 60:1322-1328.
34. McGehee, J. L., J. D. Radolf, G. B. Toews, and E. J. Hansen. 1989. Effect of primary immunization on pulmonary clearance of nontypeable Haemophilus influenzae. Am. J. Respir. Cell. Mol. Biol. 1:201-210.
35. Murphy, T. F., L. C. Bartos, P. A. Rice, M. B. Nelson, K. C. Dudas, and M. A. Apicella. 1986. Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human scrum bactericidal antibody. J. Clin. Invest. 78:1020-1027.
36. Musher, D. M., K. R. Kubitshek, J. Crennan, and R. E. Baughn. 1983. Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae. Ann. Intern. Med. 99:344-350.
37. Patrick, C. C., A. Kimura, M. A. Jackson, L. Hermanstorfer, A. Hood, G. H. McCracken, and E. J. Hansen. 1987. Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypeable Haemophilus influenzae. Infect. Immun. 55:2902-2911.
38. Phillips, N. J., M. A. Apicella, M. Griffiss, and B. W. Gibson. 1992. Structural characterization of the cell surface lipooligosaccharides from a nontypeable strain of Haemophilus influenzae. Biochemistry 31:4515-4526.
39. Phillips, N. J., M. A. Apicella, M. Griffiss, and B. W. Gibson. 1993. Structural studies of the lipooligosaccharides from Haemophilus influenzae type b strain A2+. Biochemistry 32:2003-2012.
40. Robbins, J. B., R. Schneerson, and S. C. Szu. 1995. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171:1387-1398.
41. Schneerson, R., A. Fattom, S. C. Szu, D. Bryla, J. T. Ulrich, J. A. Rudbach, G. Schiffman, and J. B. Robbins. 1991. Evaluation of monophosphoryl lipid A (MPL) as an adjuvant for human immunization: enhancement of the serum antibody response in young mice to polysaccharide-protein conjugates by concurrent injection with MPL. J. Immunol. 147:2136-2140.
42. Seid, R. C., and J. C. Sadoff. 1981. Preparation and characterization of detoxified lipopolysaccharide-protein conjugates. J. Biol. Chem. 256:7305-7310.
43. Shurin, P. A., S. I. Pelton, I. B. Tazer, and D. L. Kasper. 1980. Bactericidal antibody and susceptibility to otitis media caused by nontypcable strains of Haemophilus influenzae. J. Pediatr. 97:364-369.
44. Shurin, P. A., J. M. Rehmus, C. E. Johnson, C. D. Marchant, S. A. Carlin, D. M. Super, G. F. Van Hare, P. K. Jones, D. M. Ambrosino, and G. R. Siber. 1993. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children. J. Pediatr. 123:801-810.
45. Sirakova, T., P. E. Kollatukudy, D. Murwin, J. Billy, E. Leake, D. J. Lim, T. F. Demaria, and L. O. Bakaletz. 1994. Role of fimbriae expressed by nontypeable Haemophilus influenzae in the pathogenesis of and protection against otitis media and the relatedness of the fimbrin subunit to outer membrane protein A. Infect. Immun. 62:2002-2020.
46. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
47. Staros, J. V., R. W. Wright, and D. Swingle. 1986. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal. Biochem. 156:220-222.
48. St. Geme, J. W., III, S. Falkow, and S. J. Barenkamp. 1993. High-molecular-weight proteins of nontypeable Haemophilus influenzae mediate attachment to human epithelial cells. Proc. Natl. Acad. Sci. USA 90:2875-2879.
49. Stool, S. E., and M. J. Field. 1989. The impact of otitis media. Pediatr. Infect. Dis. Suppl. 8:S11-S14.
50. Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.
51. U.S. Pharmacopeial Convention. 1995. U.S. pharmacopoeia, 23rd rev., p. 1718. U.S. Pharmacopoeial Convention Inc., Rockville, Md.
52. Wagner, D. K., M. L. Clements, C. B. Reimer, M. Synder, D. L. Nelson, and B. R. Murphy. 1987. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum. J. Clin. Microbiol. 25:559-562.
53. Warburg, O., and W. Christian. 1942. Isolation and crystallization of enolase. Biochem. Z. 310:384-421.
54. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharide extraction with phenol:water and further application of the procedure. Methods Carbohydr. Chem. 5:83-91.
55. W. H. O. Expert Committee on Biological Standardization. 1991. Requirements for Haemophilus type b conjugate vaccines. W. H. O. Technical Report Series 814:15-37.